Precision medicine and phenotyping help tailor treatments to individual patient profiles.

The prevalence of OSA ranged from 15% to 32% across the countries. Overall, temperatures in the 99 th percentile vs the 25 th ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

AirSnore’s combination of a clinically proven mandibular advancement device and a unique blend of natural, science-backed ...

According to a new study, presented at the American College of Cardiology (ACC) Care of the Athletic Heart 2025 conference, ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Abdominal fat mass index was strongly associated with obstructive sleep apnea risk across demographic subgroups, including racial and BMI categories.

REM Sleep Behavior Disorder causes more than dream enactment—it’s a powerful clue to neurodegenerative disease risk.